G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimer’s Disease

See allHide authors and affiliations

Sci. Signal.  20 Oct 2009:
Vol. 2, Issue 93, pp. re8
DOI: 10.1126/scisignal.293re8

You are currently viewing the abstract.

View Full Text


The β-amyloid (Aβ) peptide is associated with the pathogenesis of Alzheimer’s disease (AD). Evidence gathered over the last two decades suggests that the gradual accumulation of soluble and insoluble Aβ peptide species triggers a cascade of events that leads to the clinical manifestation of AD. Aβ accumulation has also been associated with the cholinergic dysfunction observed in AD, which is characterized by diminished acetylcholine release and impaired coupling of the muscarinic acetylcholine receptors (mAChRs) to heterotrimeric GTP-binding proteins (G proteins). Although the mechanism of Aβ-mediated toxicity is not clearly understood, evidence shows that Aβ accumulation has an effect on the oligomerization of the angiotensin II (AngII) AT2 (angiotensin type 2) receptor and sequestration of the Gαq/11 family of G proteins. Sequestration of Gαq/11 results in dysfunctional coupling and signaling between M1 mAChR and Gαq/11 and accompanies neurodegeneration, tau phosphorylation, and neuronal loss in an AD transgenic mouse model. Collectively, these results provide a putative link among Aβ toxicity, AT2 receptor oligomerization, and disruption of the signaling pathway through M1 mAChR and Gαq/11 and potentially contribute to our understanding of the cholinergic deficit observed in AD.

View Full Text